Results 11 to 20 of about 482,588 (310)

Hypertension and left ventricular hypertrophy [PDF]

Annals of Translational Medicine, 2017
Left ventricular hypertrophy (LVH) is an abnormal increase in left ventricular mass. which is a marker for and contributes to coronary events, stroke, heart failure, peripheral arterial disease, and cardiovascular mortality in patients with hypertension (1-12).
W. Aronow
openaire   +4 more sources

High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning [PDF]

JAMA cardiology, 2021
This cohort study assesses the accuracy of a deep learning algorithm in measuring left ventricular dimensions and identifying patients with increased wall thickness who may benefit from additional screening for hypertrophic cardiomyopathy and cardiac ...
Grant Duffy, Paul Cheng, N. Yuan, B. He, A. Kwan, M. Shun-shin, K. Alexander, J. Ebinger, M. Lungren, F. Rader, D. Liang, I. Schnittger, E. Ashley, J. Zou, J. Patel, R. Witteles, Susan Cheng, David Ouyang   +17 more
semanticscholar   +1 more source

Reversible Treatment of Pressure Overload‐Induced Left Ventricular Hypertrophy through Drd5 Nucleic Acid Delivery Mediated by Functional Polyaminoglycoside

Advanced Science, 2021
Left ventricular hypertrophy and fibrosis are major risk factors for heart failure, which require timely and effective treatment. Genetic therapy has been shown to ameliorate hypertrophic cardiac damage.
Xiaoliang Jiang, Meiyu Shao, Xue Liu, Xing Liu, Xu Zhang, Yuming Wang, Kunlun Yin, Shuiyun Wang, Yang Hu, Pedro A Jose, Zhou Zhou, Fu‐Jian Xu, Zhiwei Yang   +12 more
doaj   +1 more source

FREQUENCY AND RISK FACTORS OF LEFT VENTRICULAR GEOMETRIC ABNORMALITIES IN HYPERTENSIVE PATIENTS: A STUDY BASED ON THE UPDATED CLASSIFICATION SYSTEM OF LEFT VENTRICULAR GEOMETRY

Pakistan Armed Forces Medical Journal, 2020
Objective: To determine the association between cardiovascular risk factors and the abnormalities of left ventricular geometric abnormalities. Study Design: Prospective cross-sectional, single centered study.
Fauzia Nazir, Tahir Iqbal, Javeria Kamran, Tariq Hussain Khattak, Anum Fatima, Aatika Habib, Saleh Kaleem   +6 more
doaj   +1 more source

The burden, correlates and outcomes of left ventricular hypertrophy among young Africans with first ever stroke in Tanzania

BMC Cardiovascular Disorders, 2021
Background Left ventricular hypertrophy is a pathophysiological response often due to chronic uncontrolled hypertension. Our primary aim was to investigate the magnitude, correlates and outcomes of left ventricular hypertrophy as a surrogate maker for ...
Sarah Shali Matuja, Patricia Munseri, Candida Moshiro, Khuzeima Khanbhai, Karim Mahawish   +4 more
doaj   +1 more source

Left ventricular hypertrophy: is it really? [PDF]

Journal of Cardiovascular Magnetic Resonance, 2013
Background Patients with left ventricular hypertrophy (LVH), typically assessed by 2D echocardiography, are at a greater risk for heart failure and sudden cardiac death. An accurate diagnosis of LVH is essential to clinical evaluation and treatment. However, 2D echo has inferior spatial resolution and less than optimal measurement positioning, relative
Nicholas C Boniface, J. Ronald Mikolich, J. Ronald Mikolich, Brandon Mikolich, Brandon Mikolich, John Lisko, John Lisko   +6 more
openaire   +3 more sources

A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial

European Heart Journal, 2020
Aim We tested the hypothesis that dapagliflozin may regress left ventricular hypertrophy (LVH) in people with type 2 diabetes (T2D). Methods and results We randomly assigned 66 people (mean age 67 ± 7 years, 38 males) with T2D, LVH, and controlled blood ...
Alexander J M Brown, S. Gandy, R. McCrimmon, J. Houston, A. Struthers, C. Lang   +5 more
semanticscholar   +1 more source

Moexipril and left ventricular hypertrophy

Vascular Health and Risk Management, 2007
George S Chrysant1, PK NguyenUniversity of Oklahoma, 1Director, Advanced Cardiac Imaging, INTEGRIS Heart Hospital, Oklahoma City, OK, USAAbstract: Angiotensin-converting enzyme (ACE) inhibitors today are the standard therapy of patients with myocardial ...
George S Chrysant, PK Nguyen
doaj   +2 more sources

Specifics of Left Ventricular Hypertrophy and Characteristic of Phenotypic Variants in Patients with Hypertrophic Cardiomyopathy

Архивъ внутренней медицины, 2023
Hypertrophic cardiomyopathy is characterized by genetic and phenotypic heterogeneity which manifests in different variants of localization and extent of myocardial hypertrophy.Aim: to evaluate specifics of left ventricular hypertrophy, the prevalence and
G. I. Ignatenko, G. G. Taradin, T. E. Kugler   +2 more
doaj   +1 more source

Left ventricular hypertrophy in athletes [PDF]

European Journal of Echocardiography, 2009
Participation in regular intensive exercise is associated with a modest increase in left ventricular wall thickness (LVWT) and cavity size. The magnitude of these physiological changes is predominantly determined by a variety of demographic factors which include age, gender, size, ethnicity, and sporting discipline.
Amit Bhan, John Rawlins, Sanjay Sharma
openaire   +3 more sources